Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · IEX Real-Time Price · USD

2.130

-0.090 (-4.05%)

At close: Apr 19, 2024, 4:00 PM

2.080

-0.050 (-2.35%)

After-hours: Apr 19, 2024, 7:19 PM EDT

Regulus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Revenue	0	0	0	10.01	6.83	0.07	0.07	1.19	20.76	7.67	Upgrade
Revenue Growth (YoY)	-	-	-	46.46%	9388.89%	0%	-93.97%	-94.25%	170.69%	-60.81%	Upgrade
Gross Profit	0	0	0	10.01	6.83	0.07	0.07	1.19	20.76	7.67	Upgrade
Selling, General & Admin	9.96	9.83	10.02	8.81	11.32	12.86	17.01	18.39	19.13	11.53	Upgrade
Research & Development	21.15	18.41	17.79	15.35	12.35	33.98	53.19	64.31	56.39	41.05	Upgrade
Operating Expenses	31.11	28.24	27.82	24.16	23.67	46.84	70.2	82.7	75.52	52.58	Upgrade
Operating Income	-31.11	-28.24	-27.82	-14.16	-16.83	-46.76	-70.13	-81.5	-54.76	-44.91	Upgrade
Interest Expense / Income	0.6	0.69	0.86	1.81	2.13	2.34	2.72	1.18	0.05	0.04	Upgrade
Other Expense / Income	-1.68	-0.61	-0.86	-0.23	-0.37	-0.46	-0.75	-0.84	0.96	11.73	Upgrade
Pretax Income	-30.04	-28.32	-27.81	-15.73	-18.59	-48.65	-72.1	-81.84	-55.77	-56.68	Upgrade
Income Tax	0	0	0	0	0	0.06	-0.2	-0	-0.02	0	Upgrade
Net Income	-30.04	-28.32	-27.81	-15.73	-18.59	-48.71	-71.91	-81.84	-55.75	-56.68	Upgrade
Shares Outstanding (Basic)	19	15	9	3	2	1	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	19	15	9	3	2	1	1	0	0	0	Upgrade
Shares Change	24.25%	78.07%	145.01%	102.65%	97.97%	39.06%	42.44%	2.74%	16.61%	14.58%	Upgrade
EPS (Basic)	-1.58	-1.86	-3.24	-4.50	-10.80	-55.90	-114.70	-185.90	-129.60	-154.80	Upgrade
EPS (Diluted)	-1.58	-1.86	-3.24	-4.50	-10.80	-55.90	-114.70	-185.90	-129.60	-154.80	Upgrade
Free Cash Flow	-27.38	-25.89	-24.38	-12.54	-19.72	-43.3	-59.08	-57.8	-51.22	-40.66	Upgrade
Free Cash Flow Per Share	-1.44	-1.70	-2.85	-3.58	-11.43	-49.66	-94.22	-131.30	-119.56	-110.65	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-141.47%	-246.40%	-64948.61%	-97404.17%	-6825.96%	-263.78%	-585.60%	Upgrade
Profit Margin	-	-	-	-157.21%	-272.13%	-67651.39%	-99868.06%	-6853.94%	-268.55%	-739.08%	Upgrade
Free Cash Flow Margin	-	-	-	-125.28%	-288.70%	-60131.94%	-82050.00%	-4840.45%	-246.75%	-530.13%	Upgrade
EBITDA	-29.21	-27.51	-26.49	-13.46	-15.53	-44.04	-66.86	-78.38	-54.12	-55.15	Upgrade
EBITDA Margin	-	-	-	-134.47%	-227.30%	-61169.44%	-92854.17%	-6564.66%	-260.72%	-719.13%	Upgrade
Depreciation & Amortization	0.23	0.12	0.46	0.47	0.93	2.26	2.52	2.28	1.59	1.49	Upgrade
EBIT	-29.43	-27.63	-26.95	-13.92	-16.46	-46.3	-69.38	-80.66	-55.71	-56.64	Upgrade
EBIT Margin	-	-	-	-139.14%	-240.93%	-64311.11%	-96359.72%	-6755.28%	-268.38%	-738.56%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).